Rémy Largillier
Centre Azuréen de Cancérologie(FR)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, BRCA gene mutations in cancer, Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies
Most-Cited Works
- → Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial(2021)145 cited
- → Outcome and prognostic factors in breast sarcoma: A multicenter study from the rare cancer network(2007)136 cited
- → Multicenter Phase II Trial of Neoadjuvant Therapy With Trastuzumab, Docetaxel, and Carboplatin for Human Epidermal Growth Factor Receptor-2–Overexpressing Stage II or III Breast Cancer: Results of the GETN(A)-1 Trial(2007)133 cited
- → New advances in DPYD genotype and risk of severe toxicity under capecitabine(2017)102 cited
- → Pharmacogenetics of Capecitabine in Advanced Breast Cancer Patients(2006)102 cited
- → Long-term results of adjuvant hypofractionated radiotherapy for breast cancer in elderly patients(2004)100 cited
- → Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial(2023)95 cited
- → Women's perceptions and experience of adjuvant tamoxifen therapy account for their adherence: breast cancer patients' point of view(2009)81 cited
- → Long-term results of hypofractionated radiotherapy and hormonal therapy without surgery for breast cancer in elderly patients(2006)73 cited
- → Predicting early death in older adults with cancer(2018)63 cited